Going to the AACR Annual Meeting? Visit our poster to find out more about a novel biomarker candidate for cancer!
The genome of a healthy person is constantly interacting with external signals and internal cues to adapt to a changing environment. Similarly, tumors also respond to the therapies aimed at removing them; chemotherapy and targeted molecular therapies can occasionally induce additional mutations or gene expression changes in tumor genomes. These secondary genetic changes are associated with increased drug resistance, recurrent forms of cancer and poorer chances of survival for patients.
Our presentation at the AACR Annual Meeting next week focuses on the correlations we identified for one such gene, sorting nexin 9 (SNX9). NextBio analysis of data correlations to SNX9 revealed several correlations of the gene to multiple types of cancer, including breast, prostate and other cancers. Read more…
